Puma Biotechnology, Inc. (PBYI)
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for the use of neratinib in combination with capecitabine for the treatment of adult patients with advanced or metastatic HER2-positive breast cancer; PB272 (neratinib, oral) for HER2 mutation-positive solid tumors. It has a license agreement with Pfizer, Inc.; and sub-license agreement with Specialised Therapeutics Asia Pte Ltd., CANbridge BIOMED Limited, Pint Pharma International SA, Knight Therapeutics, Inc., Pierre Fabre Medicament SAS, and Bixink Therapeutics Co., Ltd. The company was founded in 2010 and is headquartered in Los Angeles, California.
$158.55M
Mr. Alan H. Auerbach
196.00
Los Angeles, CA
Mar 21, 2012
17.00
$0.19
0.61
1.42
14.37%
10.60%
6.96
-0.30
2.28
0.74
1.40
10.53%
41.50%
Similar stocks (13)
Revolution Medicines, Inc.
RVMD
Madrigal Pharmaceuticals, Inc.
MDGL
Crinetics Pharmaceuticals, Inc.
CRNX
Ultragenyx Pharmaceutical Inc.
RARE
PTC Therapeutics, Inc.
PTCT
Iovance Biotherapeutics, Inc.
IOVA
Arvinas, Inc.
ARVN
Kura Oncology, Inc.
KURA
Larimar Therapeutics, Inc.
LRMR
MacroGenics, Inc.
MGNX
Heron Therapeutics, Inc.
HRTX
Coherus BioSciences, Inc.
CHRS
Hepion Pharmaceuticals, Inc.
HEPA
ETF Exposure (13)
iShares Micro-Cap ETF
IWC
0.03145%
Franklin U.S. Small Cap Multifactor Index ETF
FLQS
0.01%
iShares Russell 2000 Value ETF
IWN
0.00675%
iShares Russell 2000 ETF
IWM
0.0047%
Dimensional U.S. Small Cap ETF
DFAS
0.00443815%
iShares Russell 2000 Growth ETF
IWO
0.00293%
Dimensional U.S. Targeted Value ETF
DFAT
0.0016108700000000001%
ProShares Hedge Replication ETF
HDG
7.445565766001325e-4%
Dimensional U.S. Equity ETF
DFUS
3.9536e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.1992e-4%
WisdomTree U.S. SmallCap Earnings Fund
EES
9.3e-5%
Dimensional US Core Equity Market ETF
DFAU
6.0650000000000004e-5%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%
Similar stocks (13)
Revolution Medicines, Inc.
RVMD
Madrigal Pharmaceuticals, Inc.
MDGL
Crinetics Pharmaceuticals, Inc.
CRNX
Ultragenyx Pharmaceutical Inc.
RARE
PTC Therapeutics, Inc.
PTCT
Iovance Biotherapeutics, Inc.
IOVA
Arvinas, Inc.
ARVN
Kura Oncology, Inc.
KURA
Larimar Therapeutics, Inc.
LRMR
MacroGenics, Inc.
MGNX
Heron Therapeutics, Inc.
HRTX
Coherus BioSciences, Inc.
CHRS
Hepion Pharmaceuticals, Inc.
HEPA
ETF Exposure (13)
iShares Micro-Cap ETF
IWC
0.03145%
Franklin U.S. Small Cap Multifactor Index ETF
FLQS
0.01%
iShares Russell 2000 Value ETF
IWN
0.00675%
iShares Russell 2000 ETF
IWM
0.0047%
Dimensional U.S. Small Cap ETF
DFAS
0.00443815%
iShares Russell 2000 Growth ETF
IWO
0.00293%
Dimensional U.S. Targeted Value ETF
DFAT
0.0016108700000000001%
ProShares Hedge Replication ETF
HDG
7.445565766001325e-4%
Dimensional U.S. Equity ETF
DFUS
3.9536e-4%
Dimensional U.S. Core Equity 2 ETF
DFAC
1.1992e-4%
WisdomTree U.S. SmallCap Earnings Fund
EES
9.3e-5%
Dimensional US Core Equity Market ETF
DFAU
6.0650000000000004e-5%
Goldman Sachs ActiveBeta U.S. Small Cap Equity ETF
GSSC
0%